Table 6 Benefits of using the app: scores on adherence and well-being before and after app use (N = 11)
| Â | Pretest | Posttest | Wilcoxon signed rank test | Effect size | 95% CI for rank-biserial correlation | ||
|---|---|---|---|---|---|---|---|
Variable | Mean (SD), Mdn | Mean (SD), Mdn | W | Z (p) | Rank-biserial correlation | Lower | Upper |
Compliance (CEAT-VIH) | 13.18 (2.13), 13 | 13.09 (2.66), 14 | 27.000 |  − 0.051 (1.00) |  − 0.018 |  − 0.615 | 0.592 |
Antecedents of nonadherence (CEAT-VIH) | 17.90 (2.16), 18 | 18.45 (2.01), 20 | 4.000 |  − 0.944 (0.410) |  − 0.467 |  − 0.900 | 0.433 |
Treatment satisfaction (CEAT-VIH) | 7.63 (2.24), 8 | 8.09 (1.86), 9 | 7.000 |  − 0.734 (0.520) |  − 0.333 |  − 0.845 | 0.496 |
Doctor–patient communications (CEAT-VIH) | 12.54 (3.07), 14 | 12.63 (2.46), 14 | 12.000 |  − 0.338 (0.792) |  − 0.143 |  − 0.750 | 0.594 |
Personal beliefs and expectations about their treatment (CEAT-VIH) | 21.00 (3.46), 20 | 22.18 (2.52), 23 | 11.000 |  − 1.362 (0.189) |  − 0.511 |  − 0.862 | 0.169 |
Global adherence score (total score of the CEAT-VIH) | 72.27 (8.84), 75 | 74.45 (8.21), 78 | 15.500 |  − 1.223 (0.240) |  − 0.436 |  − 0.823 | 0.227 |
Perceived well-being (WHO-5) | 8.63 (4.52), 8 | 10.36 (4.31), 12 | 15.000 |  − 1.274 (0.220) |  − 0.455 |  − 0.830 | 0.206 |